MA41216A - Synthèse totale de trioxacarcine dc-45-a2 et préparation d'analogues de trioxacarcine - Google Patents
Synthèse totale de trioxacarcine dc-45-a2 et préparation d'analogues de trioxacarcineInfo
- Publication number
- MA41216A MA41216A MA041216A MA41216A MA41216A MA 41216 A MA41216 A MA 41216A MA 041216 A MA041216 A MA 041216A MA 41216 A MA41216 A MA 41216A MA 41216 A MA41216 A MA 41216A
- Authority
- MA
- Morocco
- Prior art keywords
- trioxacarcin
- analogues
- preparation
- total synthesis
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094662P | 2014-12-19 | 2014-12-19 | |
| US201562186128P | 2015-06-29 | 2015-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41216A true MA41216A (fr) | 2017-10-24 |
Family
ID=56127867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041216A MA41216A (fr) | 2014-12-19 | 2015-12-17 | Synthèse totale de trioxacarcine dc-45-a2 et préparation d'analogues de trioxacarcine |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10899773B2 (fr) |
| EP (1) | EP3233877A4 (fr) |
| JP (1) | JP2017537968A (fr) |
| KR (1) | KR20170122718A (fr) |
| CN (1) | CN107250144A (fr) |
| AU (1) | AU2015364347A1 (fr) |
| BR (1) | BR112017013194A2 (fr) |
| CA (1) | CA2970955A1 (fr) |
| CL (1) | CL2017001599A1 (fr) |
| CO (1) | CO2017007074A2 (fr) |
| CR (1) | CR20170331A (fr) |
| DO (1) | DOP2017000144A (fr) |
| EA (1) | EA201791388A1 (fr) |
| EC (1) | ECSP17046657A (fr) |
| GT (1) | GT201700139A (fr) |
| HK (1) | HK1243422A1 (fr) |
| IL (1) | IL252947A0 (fr) |
| MA (1) | MA41216A (fr) |
| MX (1) | MX2017008162A (fr) |
| PE (1) | PE20171787A1 (fr) |
| PH (1) | PH12017501147A1 (fr) |
| SG (1) | SG11201704935XA (fr) |
| WO (1) | WO2016100833A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210230178A1 (en) * | 2017-08-17 | 2021-07-29 | William Marsh Rice University | Trioxacarcin analogs and dimers as potent anticancer agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5815995A (ja) | 1981-07-22 | 1983-01-29 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法 |
| EP0157203A3 (fr) | 1984-04-04 | 1986-10-01 | American Cyanamid Company | Agents antitumoraux LL-D49194 alpha 1, LL-D49194 bêta 1, LL-D49194 bêta 2, LL-D49194 bêta 3, LL-D49194 gamma, LL-D49194 delta, LL-D49194 epsilon, LL-D49194 dzéta, LL-D49194 êta LL-D499194 oméga 1, LL-D49194 oméga 2 et LL-D49194 oméga 3 |
| JPS63135389A (ja) | 1986-11-26 | 1988-06-07 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５類の誘導体 |
| WO2011119549A1 (fr) * | 2010-03-22 | 2011-09-29 | President And Fellows Of Harvard College | Trioxacarcines et utilisations de celles-ci |
| US9775915B2 (en) | 2012-11-26 | 2017-10-03 | President And Fellows Of Harvard College | Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof |
-
2015
- 2015-12-17 MA MA041216A patent/MA41216A/fr unknown
- 2015-12-18 CA CA2970955A patent/CA2970955A1/fr not_active Abandoned
- 2015-12-18 MX MX2017008162A patent/MX2017008162A/es unknown
- 2015-12-18 SG SG11201704935XA patent/SG11201704935XA/en unknown
- 2015-12-18 WO PCT/US2015/066703 patent/WO2016100833A2/fr active Application Filing
- 2015-12-18 US US15/537,319 patent/US10899773B2/en active Active
- 2015-12-18 JP JP2017532666A patent/JP2017537968A/ja not_active Withdrawn
- 2015-12-18 EA EA201791388A patent/EA201791388A1/ru unknown
- 2015-12-18 KR KR1020177020092A patent/KR20170122718A/ko unknown
- 2015-12-18 AU AU2015364347A patent/AU2015364347A1/en not_active Abandoned
- 2015-12-18 CR CR20170331A patent/CR20170331A/es unknown
- 2015-12-18 BR BR112017013194-3A patent/BR112017013194A2/pt not_active Application Discontinuation
- 2015-12-18 CN CN201580076346.2A patent/CN107250144A/zh active Pending
- 2015-12-18 EP EP15871176.2A patent/EP3233877A4/fr not_active Withdrawn
- 2015-12-18 PE PE2017001101A patent/PE20171787A1/es unknown
-
2017
- 2017-06-15 IL IL252947A patent/IL252947A0/en unknown
- 2017-06-19 PH PH12017501147A patent/PH12017501147A1/en unknown
- 2017-06-19 GT GT201700139A patent/GT201700139A/es unknown
- 2017-06-19 DO DO2017000144A patent/DOP2017000144A/es unknown
- 2017-06-19 CL CL2017001599A patent/CL2017001599A1/es unknown
- 2017-07-14 CO CONC2017/0007074A patent/CO2017007074A2/es unknown
- 2017-07-19 EC ECIEPI201746657A patent/ECSP17046657A/es unknown
-
2018
- 2018-02-28 HK HK18102899.8A patent/HK1243422A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107250144A (zh) | 2017-10-13 |
| MX2017008162A (es) | 2018-03-06 |
| WO2016100833A2 (fr) | 2016-06-23 |
| CO2017007074A2 (es) | 2017-10-20 |
| PE20171787A1 (es) | 2017-12-28 |
| BR112017013194A2 (pt) | 2018-01-02 |
| DOP2017000144A (es) | 2017-09-29 |
| JP2017537968A (ja) | 2017-12-21 |
| KR20170122718A (ko) | 2017-11-06 |
| ECSP17046657A (es) | 2019-03-29 |
| AU2015364347A1 (en) | 2017-07-13 |
| US10899773B2 (en) | 2021-01-26 |
| HK1243422A1 (zh) | 2018-07-13 |
| IL252947A0 (en) | 2017-08-31 |
| EP3233877A4 (fr) | 2018-10-17 |
| CA2970955A1 (fr) | 2016-06-23 |
| CL2017001599A1 (es) | 2018-11-09 |
| PH12017501147A1 (en) | 2018-03-05 |
| WO2016100833A3 (fr) | 2017-01-05 |
| EA201791388A1 (ru) | 2017-11-30 |
| GT201700139A (es) | 2018-10-24 |
| US20190023717A1 (en) | 2019-01-24 |
| CR20170331A (es) | 2017-11-17 |
| EP3233877A2 (fr) | 2017-10-25 |
| SG11201704935XA (en) | 2017-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201704985B (en) | Oral care compositions and methods of use | |
| ZA201703834B (en) | Oral care compositions and methods of use | |
| MA49715A (fr) | Oligomères et conjugués d'oligomères | |
| MA46180A (fr) | Analogues de l'amyline | |
| GB201500314D0 (en) | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension | |
| EP3160970A4 (fr) | Synthèse d'analogues d'halochondrines et leurs utilisations | |
| IL280690A (en) | Pharmaceutical preparations that include DGLA and their use | |
| MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
| PT3380525T (pt) | Formulações farmacêuticas e métodos que as utilizam | |
| ZA201801015B (en) | Oral care compositions and methods of using the compositions | |
| HK1217689A1 (zh) | 及其生物活性類似物的合成 | |
| DK3319980T3 (da) | Formuleringer til forbedring af virkningen af hydrofobe lægemidler | |
| IL267279A (en) | Pharmaceutical formulations of suvorexant | |
| IL258304A (en) | Oral care compounds and methods for using the compounds | |
| IL250846A0 (en) | Synthesis of cyclocreatin and its analogs | |
| MA43126A (fr) | Compositions pharmaceutiques de fumarate de diméthyle | |
| MA43166A (fr) | Formulation de fviii | |
| MA42273A (fr) | Synthèse totale de shishijimicine a et d'analogues de celle-ci | |
| MA41216A (fr) | Synthèse totale de trioxacarcine dc-45-a2 et préparation d'analogues de trioxacarcine | |
| HK1245015A1 (zh) | 環肌酸及其類似物的合成 | |
| FR3016128B1 (fr) | Tete de distribution et d'application. | |
| GB201516437D0 (en) | Compositions and methods relating to the treatment of disease | |
| TH1501005637A (th) | องค์ประกอบเครื่องสำอางของผิวหนัง | |
| FR3029380B1 (fr) | Declenchement conditionne d'applications interactives | |
| TH1601003772A (th) | อะนาล็อกคอร์ทิสทาทินและการสังเคราะห์และการใช้งานของสารเหล่านั้น |